CA2416603A1 - Inhibiting hepatitis c virus processing and replication - Google Patents
Inhibiting hepatitis c virus processing and replication Download PDFInfo
- Publication number
- CA2416603A1 CA2416603A1 CA002416603A CA2416603A CA2416603A1 CA 2416603 A1 CA2416603 A1 CA 2416603A1 CA 002416603 A CA002416603 A CA 002416603A CA 2416603 A CA2416603 A CA 2416603A CA 2416603 A1 CA2416603 A1 CA 2416603A1
- Authority
- CA
- Canada
- Prior art keywords
- hsp90
- cleavage
- hcv
- processing
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21955000P | 2000-07-20 | 2000-07-20 | |
US60/219,550 | 2000-07-20 | ||
PCT/US2001/022335 WO2002007761A1 (en) | 2000-07-20 | 2001-07-16 | Inhibiting hepatitis c virus processing and replication |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2416603A1 true CA2416603A1 (en) | 2003-01-31 |
Family
ID=22819717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002416603A Abandoned CA2416603A1 (en) | 2000-07-20 | 2001-07-16 | Inhibiting hepatitis c virus processing and replication |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1322325A4 (de) |
JP (1) | JP2004504356A (de) |
CA (1) | CA2416603A1 (de) |
WO (1) | WO2002007761A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004505044A (ja) * | 2000-07-28 | 2004-02-19 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | 細胞増殖性障害およびウイルス感染の治療方法 |
MY148123A (en) | 2003-09-05 | 2013-02-28 | Vertex Pharma | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
DE10361944A1 (de) * | 2003-12-31 | 2005-07-28 | Viromics Gmbh | Mittel zur Hemmung der Virusreplikation durch Regulation der Proteinfaltung |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
DK1719773T3 (da) | 2004-02-24 | 2009-06-29 | Japan Tobacco Inc | Kondenserede heterotetracykliske forbindelser og anvendelse deraf som HCV-polymeraseinhibitor |
DE102004049078A1 (de) | 2004-10-08 | 2006-04-13 | Merck Patent Gmbh | Phenylpyrazole |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
DE102005009440A1 (de) | 2005-03-02 | 2006-09-07 | Merck Patent Gmbh | Thienopyridinderivate |
AR055395A1 (es) | 2005-08-26 | 2007-08-22 | Vertex Pharma | Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c |
WO2007058384A1 (en) * | 2005-11-17 | 2007-05-24 | Osaka University | Method of suppressing replication of hepatitis c virus, inhibitor of replication of the virus and method of screening for the same |
JP2007238442A (ja) * | 2006-02-07 | 2007-09-20 | Hiroshi Takaku | 抗ウイルス剤 |
US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
DE102006030479A1 (de) | 2006-07-01 | 2008-03-20 | Merck Patent Gmbh | Indazolderivate |
DE102007002715A1 (de) | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Triazolderivat |
DE102007028521A1 (de) | 2007-06-21 | 2008-12-24 | Merck Patent Gmbh | Indazolamidderivate |
DE102007032739A1 (de) | 2007-07-13 | 2009-01-15 | Merck Patent Gmbh | Chinazolinamidderivate |
DE102007041116A1 (de) | 2007-08-30 | 2009-03-05 | Merck Patent Gmbh | 1,3-Dihydro-isoindolderivate |
US9101628B2 (en) | 2007-09-18 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and composition of treating a flaviviridae family viral infection |
US8895598B2 (en) | 2007-09-18 | 2014-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
US8940730B2 (en) | 2007-09-18 | 2015-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions of treating a Flaviviridae family viral infection |
US9149463B2 (en) | 2007-09-18 | 2015-10-06 | The Board Of Trustees Of The Leland Standford Junior University | Methods and compositions of treating a Flaviviridae family viral infection |
DE102008061214A1 (de) | 2008-12-09 | 2010-06-10 | Merck Patent Gmbh | Chinazolinamidderivate |
JP2012520885A (ja) * | 2009-03-18 | 2012-09-10 | ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー | フラビウイルス科ウイルス感染症を治療する方法および組成物 |
CN102448458B (zh) | 2009-03-18 | 2015-07-22 | 小利兰·斯坦福大学理事会 | 治疗黄病毒科病毒感染的方法和组合物 |
DE102009054302A1 (de) | 2009-11-23 | 2011-05-26 | Merck Patent Gmbh | Chinazolinderivate |
DE102010046837A1 (de) | 2010-09-29 | 2012-03-29 | Merck Patent Gmbh | Phenylchinazolinderivate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837251A (en) * | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
CN1099870C (zh) * | 1997-01-28 | 2003-01-29 | 陶佩珍 | 格尔德霉素在制备新型广谱抗病毒药物中的用途 |
-
2001
- 2001-07-16 EP EP01952780A patent/EP1322325A4/de not_active Withdrawn
- 2001-07-16 CA CA002416603A patent/CA2416603A1/en not_active Abandoned
- 2001-07-16 JP JP2002513494A patent/JP2004504356A/ja not_active Withdrawn
- 2001-07-16 WO PCT/US2001/022335 patent/WO2002007761A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2004504356A (ja) | 2004-02-12 |
EP1322325A4 (de) | 2004-09-15 |
EP1322325A1 (de) | 2003-07-02 |
WO2002007761A1 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2416603A1 (en) | Inhibiting hepatitis c virus processing and replication | |
Shiryaev et al. | Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists | |
CA3180177A1 (en) | Protease inhibitors for treatment or prevention of coronavirus disease | |
Burnett et al. | Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection | |
Lee et al. | The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein | |
Jaeschke et al. | Protection against TNF-induced liver parenchymal cell apoptosis during endotoxemia by a novel caspase inhibitor in mice | |
CN111886008A (zh) | 用于广谱抗病毒治疗的组合物和方法 | |
US20090203770A1 (en) | COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING Bcl-2 FAMILY MEMBER PROTEINS | |
US8187874B2 (en) | Drug discovery method | |
Borowski et al. | Non‐Structural Protein 3 of Hepatitis C Virus Inhibits Phosphorylation Mediated by cAMP‐Dependent Protein Kinase | |
US7241804B1 (en) | Compositions and methods for modulating apoptosis in cells over-expressing Bcl-2 family member proteins | |
TW200528472A (en) | Inhibitors of serine proteases, particularly HCV ns3-ns4a protease | |
KR20000075983A (ko) | 헤파타이티스 c 바이러스 복제를 선택적으로 저해하는 물질을 확인하기 위한 새로운 스크리닝 방법 | |
TW201300108A (zh) | C型肝炎病毒(hcv)ns3-ns4a蛋白酶抑制劑 | |
WO2000024725A1 (en) | Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase | |
US6080791A (en) | Method of treating a viral condition by inhibiting membrane fusion | |
EP3738603A1 (de) | Ntcp-inhibitor | |
US20030211469A1 (en) | Inhibiting hepatitis c virus processing and replication | |
Ciccaglione et al. | The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death | |
Allen et al. | Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo | |
Pászti-Gere et al. | In vitro interaction of potential antiviral TMPRSS2 inhibitors with human serum albumin and cytochrome P 450 isoenzymes | |
Moghadasi et al. | Gain-of-function assay for SARS-CoV-2 Mpro inhibition in living cells | |
WO2001016379A1 (en) | Hepatitis c virus replication inhibitors | |
WO2021155798A1 (zh) | 免疫多肽在抗病毒药物中的应用 | |
Rakic et al. | A small-molecule probe for hepatitis C virus replication that blocks protein folding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |